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Abstract
Some commensal bacterial species have the ability to block the growth
of harmful pathogens. The focus of this research was to evaluate
different commensal nasal swab isolates’ capability to inhibit the
colonization of the opportunistic pathogen Staphylococcus aureus. An
Interspecies Inhibition assay was conducted to determine the potential
growth inhibition of 16 non-S. aureus strains against four characterized
S. aureus isolates. After conducting the research, three commensal
nasal isolates (0879, 0880, and 0887) all inhibited the growth of S.
aureus strain S0037. Additionally, commensal nasal isolate 0887 did not
inhibit the growth of S. aureus strain S0028. These results suggest that
the commensal isolates exhibiting growth inhibition possess
antimicrobial activity that confirm the role of commensal nasal bacteria
in limiting the virulence of S. aureus.

Methodology

Authenticating the Variation of Growth
Inhibition Capacity Among Commensal
Nasal Swab Isolates 0879, 0880, and 0887
Against Staphylococcus aureus Strains
S0023, S0025, S0028, and S0037.

Grow 1 colony of S. aureus from TSA plate in
a sterile liquid culture tube containing 3mL
TSB in the incubator for 24 hours at 37°C.
Insert blank cuvette into
spectrophotometer, then pipette 1.5mL S.
aureus liquid culture into new cuvette and
record bacterial concentration at 600nm.

Label TSA plate with a 4x4 grid -16
numbered squares for each nasal isolate.
Dip sterile swab into sterile liquid culture
tube once and streak onto TSA plate
using a 3-way lawn technique.

Introduction
• Staphylococcus aureus (S. aureus) is a clinically relevant Grampositive opportunistic pathogen that colonizes the anterior nares
(nostrils) of approximately 30% of the human population.¹
• As a commensal member of the human microbiota, the presence of
S. aureus does not typically cause harm. However, once the
bacterium is allowed entry into the internal tissues or bloodstream,
S. aureus can cause a variety of invasive and often life-threatening
clinical manifestations, such as endocarditis, osteomyelitis, and Toxic
Shock Syndrome (TSS).
• Treatment of Staphylococcus aureus remains challenging due to the
emergence of multi-drug resistant strains such as Methicillin
Resistant Staphylococcus aureus (MRSA) that confer resistance to
the β-lactam antibiotics commonly used to treat S. aureus
infections.²

Pull 1 colony from each of the 16
commensal nasal isolates and gently
streak on top of freshly swabbed S.
aureus in the form of an “X,” using a
sterile toothpick each time.

Incubate plate at 37°C. Take
images and assess growth
inhibition at 24 and 48 hours.

Conclusion

Interspecies Inhibition

•

• Previous research has confirmed the ability of some species of
commensal bacteria to block colonization of pathogenic bacteria
such as S. aureus in the nasal cavity through their antimicrobial
activity and strong competition for space and nutrients.
• One human nasal commensal identified to have a particularly
strong capacity to block S. aureus colonization is S. lugdunensis
IVK28.
• S. lugdunensis produces lugdunin, a peptide antibiotic that has
potent antimicrobial activity against many major human pathogens
including S. aureus. This suggests that lugdunin-producing
commensal bacteria may be used to prevent S. aureus infections.³
• Interspecies Inhibition is a bacterial interaction assay that is
conducted by co-culturing two bacterial species to analyze the
antimicrobial potential of commensal nasal isolates against S.
aureus.
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•

Ultimately, evaluating the ability of commensal bacteria within the
nasal microbiota to inhibit the colonization of S. aureus may
provide a guideline for the ultimate development of novel therapies
and/or alternative antibiotic treatments for S. aureus infections.

Three commensal nasal swab isolates 0879, 0880, and 0887
demonstrated the ability to block the growth of S.aureus strain
S0037.
Commensal nasal iolate 0887 indicated growth inhibition capacity
against S.aureus strains S0023, S0025, and S0037, but did not
suppress the growth of S. aureus strain S0028.
Variation of growth inhibition potential among commensal nasal
isolate 0887 validates the importance of testing multiple different
strains of human commensals against S. aureus. Each commensal
nasal isolate does not individually possess the capacity to block
colonization of all strains of S. aureus. Thus, conclusions cannot be
made about the isolate’s therapeutic potential when other strains of
S. aureus are still able to colonize.
Results indicate that the select commensal nasal swab isolates
exhibiting growth inhibition possess specific microbial compounds
that are toxic to S. aureus, as proven in their ability to block the
colonization of S. aureus when co-cultured in an Interspecies
Inhibition assay.
The antimicrobial compounds produced by inhibitory commensal
nasal isolates may be used in further research to discover new
antimicrobials to treat S. aureus and other opportunistic pathogens.
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